Cited by 137Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Neuropathologic Studies of the Baltimore Longitudinal Study of Aging (BLSA)

Open access
O'Brien, Richard J., Resnick, Susan M., Zonderman, Alan B., Ferrucci, Luigi, Crain, Barbara J., Pletnikova, Olga, Rudow, Gay, Iacono, Diego +5 more·2009·Journal of Alzheimer's Disease

Abstract

The Baltimore Longitudinal Study of Aging (BLSA) was established in 1958 and is one the oldest prospective studies of aging in the USA and the world. The BLSA is supported by the National Institute of Aging (NIA) and its mission is to learn what happens to people as they get old and how to sort out changes due to aging from those due to disease or other causes. In 1986, an autopsy program combined with comprehensive neurologic and cognitive evaluations was established in collaboration with the Johns Hopkins University Alzheimer's Disease Research Center (ADRC). Since then, 211 subjects have undergone autopsy. Here we review the key clinical neuropathological correlations from this autopsy series. The focus is on the morphological and biochemical changes that occur in normal aging, and the early neuropathological changes of neurodegenerative diseases, especially Alzheimer's disease (AD). We highlight the combined clinical, pathologic, morphometric, and biochemical evidence of asymptomatic AD, a state characterized by normal clinical evaluations in subjects with abundant AD pathology. We conclude that in some individuals, successful cognitive aging results from compensatory mechanisms that occur at the neuronal level (i.e., neuronal hypertrophy and synaptic plasticity) whereas a failure of compensation may culminate in disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-2009-1179

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 30

  1. [2]Kawas C Gray S Brookmeyer R Fozard J Zonderman A 2000 Age-specific incidence rates of Alzheimer’s disease: the Baltimore Longitudinal Study of Aging Neurology 54 2072 2077 10851365
  2. [3]Hughes CP Berg L Danziger WL Coben LA Martin RL 1982 A new clinical scale for the staging of dementia Br J Psychiatry 140 566 572 7104545
  3. [4]Morris JC Ernesto C Schafer K Coats M Leon S Sano M Thal LJ Woodbury P 1997 Clinical dementia rating training and reliability in multicenter studies: the Alzheimer’s Disease Cooperative Study experience Neurology 48 1508 1510 9191756
  4. [5]Silverman JM Breitner JC Mohs RC Davis KL 1986 Reliability of the family history method in genetic studies of Alzheimer’s disease and related dementias Am J Psychiatry 143 1279 1282 3766791
  5. [7]Association AP 1987 Diagnostic and Statistical Manual of Mental Disorders 3 Revised (DSM-II-R) Washington D.C. American Psychiatric Press, Inc
  6. [8]Petersen RC 2004 Mild cognitive impairment as a diagnostic entity J Intern Med 256 183 194 15324362
  7. [9]Yamamoto T Hirano A 1986 A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer’s neurofibrillary tangles Neuropathol Appl Neurobiol 12 3 9 2422580
  8. [10]Mirra SS Heyman A McKeel D Sumi SM Crain BJ Brownlee LM Vogel FS Hughes JP van Belle G Berg L 1991 The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease Neurology 41 479 486 2011243
  9. [12]Hughes AJ Daniel SE Blankson S Lees AJ 1993 A clinicopathologic study of 100 cases of Parkinson’s disease Arch Neurol 50 140 148 8431132
  10. [14]Troncoso JC Martin LJ Dal Forno G Kawas CH 1996 Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging Neurobiol Aging 17 365 371 8725897
  11. [17]Lue LF Brachova L Civin WH Rogers J 1996 Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer’s disease neurodegeneration J Neuropathol Exp Neurol 55 1083 1088 8858005
  12. [18]Benzing WC Mufson EJ Armstrong DM 1993 Immunocytochemical distribution of peptidergic and cholinergic fibers in the human amygdala: their depletion in Alzheimer’s disease and morphologic alteration in non-demented elderly with numerous senile plaques Brain Res 625 125 138 8242391
  13. [19]Riudavets MA Iacono D Resnick SM O’Brien R Zonderman AB Martin LJ Rudow G Pletnikova O Troncoso JC 2007 Resistance to Alzheimer’s pathology is associated with nuclear hypertrophy in neurons Neurobiol Aging 28 1484 1492 17599696 PMC2694127
  14. [21]Katzman R 1993 Education and the prevalence of dementia and Alzheimer’s disease Neurology 43 13 20 8423876
  15. [25]Sze CI Bi H Kleinschmidt-DeMasters BK Filley CM Martin LJ 2000 Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer’s disease brains J Neurol Sci 175 81 90 10831767
  16. [26]Martin LJ Ramachandran VS 2002 Neurodegenerative Disorders Encyclopedia of the Human Brain Elsevier Science 3 441 463
  17. [28]Crystal H Dickson D Fuld P Masur D Scott R Mehler M Masdeu J Kawas C Aronson M Wolfson L 1988 Clinicopathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer’s disease Neurology 38 1682 1687 3185902
  18. [29]Stern Y Jacobs D Goldman J Gomez-Tortosa E Hyman BT Liu Y Troncoso J Marder K Tang MX Brandt J Albert M 2001 An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer disease Arch Neurol 58 460 465 11255450
  19. [30]Price JL Morris JC 1999 Tangles and plaques in nondemented aging and preclinical Alzheimer’s disease Ann Neurol 45 358 368 10072051
  20. [34]Morgan MD Mielke MM O’Brien R Troncoso JC Zonderman AB Lyketsos CG 2007 Rates of depression in individuals with pathologic but not clinical Alzheimer disease are lower than those in individuals without the disease: findings from the Baltimore Longitudinal Study on Aging (BLSA) Alzheimer Dis Assoc Disord 21 199 204 17804951 PMC2607061
  21. [35]Morgan D Gitter BD 2004 Evidence supporting a role for anti-Abeta antibodies in the treatment of Alzheimer’s disease Neurobiol Aging 25 605 608 15172737
  22. [36]Snowdon DA Greiner LH Mortimer JA Riley KP Greiner PA Markesbery WR 1997 Brain infarction and the clinical expression of Alzheimer disease. The Nun Study Jama 277 813 817 9052711
  23. [38]Esiri MM Nagy Z Smith MZ Barnetson L Smith AD 1999 Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease Lancet 354 919 920 10489957
  24. [39]2001 Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) Lancet 357 169 175 11213093
  25. [41]Sonnen JA Larson EB Crane PK Haneuse S Li G Schellenberg GD Craft S Leverenz JB Montine TJ 2007 Pathological correlates of dementia in a longitudinal, population-based sample of aging Ann Neurol 62 406 413 17879383
  26. [43]Troncoso JC Zonderman AB Resnick SM Crain B Pletnikova O O’Brien RJ 2008 Effect of infarcts on dementia in the Baltimore longitudinal study of aging Ann Neurol 64 168 176 18496870 PMC2694129
  27. [44]Aarsland D Andersen K Larsen JP Lolk A Nielsen H Kragh-Sorensen P 2001 Risk of dementia in Parkinson’s disease: a community-based, prospective study Neurology 56 730 736 11274306
  28. [45]Jellinger KA 2006 The morphological basis of mental dysfunction in Parkinson’s disease J Neurol Sci 248 167 172 16797594
  29. [46]Rudow G O’Brien R Savonenko AV Resnick SM Zonderman AB Pletnikova O Marsh L Dawson TM Crain BJ West MJ Troncoso JC 2008 Morphometry of the human substantia nigra in ageing and Parkinson’s disease Acta Neuropathol 115 461 470 18297291 PMC2431149
  30. [47]Mikolaenko I Pletnikova O Kawas CH O’Brien R Resnick SM Crain B Troncoso JC 2005 Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA) J Neuropathol Exp Neurol 64 156 162 15751230

Cited by

Sorted by citations

Authors
O'Brien, R. J., Resnick, S. M., Zonderman, A. B., Ferrucci, L., Crain, B. J., Pletnikova, O., Rudow, G., Iacono, D., Riudavets, M. A., Driscoll, I., Price, D. L., Martin, L. J., & Troncoso, J. C.
Affiliations
  • Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
  • National Institutes of Health (US)
  • Johns Hopkins University (US)
  • Division of Neuropathology, Department of Pathology, Johns Hopkins University, Baltimore, MD, USA
  • Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (AR)
Venue
Journal of Alzheimer's Disease
Published
2009-10-30
Volume
18
Issue
3
Pages
665-675
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W1498301041
Cited by
137
References
16
Citations by year
2026: 1 · 2025: 9 · 2024: 12 · 2023: 10 · 2022: 4 · 2021: 16 · 2020: 12 · 2019: 7 · 2018: 9 · 2017: 9 · 2016: 6 · 2015: 9 · 2014: 9 · 2013: 7 · 2012: 8
FWCI
3.49
Type
journal article
Language
en
Open access
Locations
  • Journal of Alzheimer s Disease (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Johns Hopkins University
  • National Institutes of Health
  • National Institute on Aging (Z01AG000191, P50AG005146, AG 05146, ZIAAG000185)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Baltimore Longitudinal Study of Aging, autopsy
MeSH terms
Aged, Aged, 80 and over, Aging, Alzheimer Disease, Brain, Dementia, Female, Follow-Up Studies, Humans, Male, Parkinson Disease, Tissue Donors, Baltimore, Amyloid beta-Peptides, tau Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review